Skip to main content

A Pivotal Phase 3 Randomized, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of the sGC Stimulator Vericiguat/MK-1242 in Adults With Chronic Heart Failure With Reduced Ejection Fraction

Open
  • Protocol code: MK-1242-035
  • EudraCT code: 2020-005941-18
  • Research group: Cardiovascular Diseases
  • Service: Cardiology
  • Principal investigator:  Méndez Fernández, Ana Belén
  • Pathology: Malalties del sistema circulatori
  • Phase: Fase III
  • Status: Recruiting volunteers